The national key research and development plan project led by Juzhi Biology has made new progress.

Recently, the National Key Research and Development Program's key special project "Disease Biomarker Single-Molecule Immunosensitive Elements and Analytical Instruments" held its 2025 annual work summary meeting at the Juguang Science and Technology Industrial Park. The meeting was organized by Juguang Technology's life science business unit, Juzhi Bio. The meeting systematically summarized the project's annual progress and deployed key technologies, system optimization, and clinical validation for the next phase, further clarifying the project's direction for subsequent acceptance and application promotion. Currently, the project team has conducted phase clinical sample validation and produced interim results such as papers and intellectual property rights, laying the foundation for future application research.